Doc Talk by MedAudPro podcast

Fully Implanted Cochlear Implants: The Next Frontier in Hearing Healthcare

0:00
35:52
Rewind 15 seconds
Fast Forward 15 seconds

Fully implanted cochlear implants are moving closer to the market, potentially changing how patients experience hearing and how providers approach cochlear implant care. Could eliminating the external sound processor also encourage more eligible adults to consider implantation?

In this episode, Brent Lucas, CEO of Envoy Medical, joins MedAudPro Doc Talk to discuss the future of fully implanted cochlear implants, including Envoy's investigational Acclaim system, and what emerging technology could mean for patients, audiologists, and surgeons.

With more than 17 years of experience in active implantable hearing devices, Brent shares his perspective on innovation, patient priorities, and the challenges of bringing new technology to market.

What You'll Hear:

Why CI Utilization Remains Low: Could concerns about wearing external devices be one reason eligible adults hesitate to pursue cochlear implantation?

Beyond Hearing Outcomes: Why independence, lifestyle, convenience, and patient preferences deserve more attention alongside traditional clinical measures.

The Potential for 24/7 Hearing: What continuous hearing could mean for nighttime safety, family responsibilities, travel, and everyday life.

How Fully Implanted Technology Works: A look at Acclaim's middle ear sensor, chest-based rechargeable battery, and how its design differs from traditional cochlear implants.

What's Next for the Industry: With Envoy Medical, Cochlear, and MED-EL developing fully implanted technologies, what can providers expect over the next few years?

Preparing for New Patient Conversations: How emerging technology could influence candidacy counseling, referrals, reimbursement, and collaboration between audiologists and surgeons.

The bigger question isn't simply whether cochlear implants can become fully implanted. It's whether these technologies could change who considers implantation and what patients expect from their hearing healthcare.

Who should listen?

Audiologists, otologists, neurotologists, cochlear implant teams, ENT providers, hearing healthcare professionals, researchers, and anyone interested in the future of cochlear implant care.

This episode concludes the MedAudPro Doc Talk Cochlear Implant Series and launches our FCOM Speaker Series, highlighting professionals participating in the 30th Annual Florida Combined Otolaryngology Meeting, November 12–15, 2026.

Important Note: Envoy Medical's Acclaim cochlear implant is investigational and is not FDA approved. This discussion is for educational purposes only. Other manufacturers' devices are discussed for context.

The MedAudPro Doc Talk Cochlear Implant Series is sponsored by Envoy Medical.

Follow @MedAudPro on LinkedIn, Facebook, and Instagram.

Learn more about FCOM: https://FCOMnow.com

Join the MedAudPro Provider Community: https://medaudpro.com/join

Add the FCOM session teaserClarify the episode’s sponsored status

More episodes from "Doc Talk by MedAudPro"